1Hermida RC, Ayala DE, Calvo C, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives[ J ]. Hypertension, 2005, 46 (4) : 1060- 1068.
2Hermida RC, Ayala DE, Calvo C, et al. Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients[J]. J Am Coll Cardiol,2005,46(6) : 975-983.
3Peterson JG, Topol EJ, Sapp SK, et al. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease [ J ]. Am J Med, 2000, 109 (5) :371-377.
4Hennekens CH. Update on aspirin in the treatment and prevention of cardiovascular disease[J]. Am J Manag Care,2002,8( Suppl 22) : 691-700.
6Bell DM. Markers for progression of coronary disease[J]. Pharmacotherapy, 2001,21 (9) : 190-194.
7Spieker LE,Noll G. Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis [J]. J Cardiovasc Pharmacol, 2001,38 ( Suppl 2) : S35-S41.
5Marshall T. Coronary heart disease prevention: insights from modelling incremental cost effectiveness [ J 1. BMJ,2003,327 ( 7426 ): 1264-1268.
6Antiplatelet trialists collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients[J]. BMJ, 1994, 308: 81-106.
7Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients[J]. BMJ, 2002, 324(12): 71-86.
8Hung J. Aspirin for cardiovascular disease prevention [J]. Med J Aust, 2003 Aug 4,179(3): 147-152.
9Sacco R L, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with isehemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline[J]. Stroke, 2006, 37(2): 577-617.
